Dit is een post van een voorgestelde groep
Enhancing Patient Safety and Resource Utilization Through Strategic Interventions in the Patient Blood Management Market
The Patient Blood Management (PBM) Market is driven by a multidisciplinary, evidence-based approach designed to optimize the care of patients who might need a blood transfusion. PBM programs aim to reduce the need for transfusions by treating anemia, minimizing blood loss, and harnessing the patient's own physiological reserves, thereby conserving blood supplies and improving patient outcomes. This shift is critical because blood transfusions, while often lifesaving, are associated with risks, including immunological reactions, infections, and even increased mortality in certain contexts. The PBM market includes diagnostic tests for anemia and coagulopathy, software for clinical decision support, and devices for intraoperative blood salvage. The economic argument for PBM is compelling: by reducing transfusion rates, hospitals save money on procurement, testing, storage, and handling of blood products, while also lowering the cost of treating transfusion-related adverse events.…